TERAPIA DE REEMPLANZO DE TESTOSTERONA EM HOMBRES COM DIABETES MELLITUS TIPO 2: REVISIÓN BIBLIOGRÁFICA
DOI:
https://doi.org/10.47820/recima21.v6i7.6610Palabras clave:
Esteroides Anabólicos Androgénicos; Diabetes Mellitus; Terapéutica.Resumen
La Diabetes Mellitus tipo 2 (DM2) está asociada a disfunciones hormonales, como la reducción de la testosterona libre y biodisponible, especialmente en hombres. La terapia de reemplazo de testosterona (TRT) ha surgido como una estrategia complementaria para mejorar el control glucémico, la composición corporal y los parámetros cardiovasculares en pacientes diabéticos con hipogonadismo. Este artículo revisa los principales mecanismos y evidencias clínicas que respaldan el uso de esteroides anabólicos androgénicos como adyuvante terapéutico en la DM2, señalando beneficios en la sensibilidad a la insulina, el perfil inflamatorio y la fuerza muscular.
Descargas
Referencias
DHINDSA, Sandeep et al. Insulin resistance and inflammation in hypogonadotropic hypogonadism and their reduction after testosterone replacement in men with type 2 diabetes. Diabetes care, v. 39, n. 1, p. 82-91, 2016. DOI: https://doi.org/10.2337/dc15-1518
DING, Bo et al. Men with Latent Autoimmune Diabetes and Type 2 Diabetes May Have Different Change Patterns in Free Testosterone. BioMed Research International, v. 2020, n. 1, p. 6259437, 2020. DOI: https://doi.org/10.1155/2020/6259437
GROTI ANTONIČ, Kristina. Impact of testosterone therapy on bone turnover markers in obese males with type 2 diabetes and functional hypogonadism. The Aging Male, v. 25, n. 1, p. 269-277, 2022. DOI: https://doi.org/10.1080/13685538.2022.2134338
GROTI, Kristina et al. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes. The Aging Male, v. 21, n. 3, p. 158-169, 2018. DOI: https://doi.org/10.1080/13685538.2018.1468429
KHRIPUN, Irina et al. Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial. The Aging Male, 2019. DOI: https://doi.org/10.1080/13685538.2018.1506918
KOVAC, Jason R. et al. A positive role for anabolic androgenic steroids: preventing metabolic syndrome and type 2 diabetes mellitus. Fertility and Sterility, v. 102, n. 1, p. e5, 2014. DOI: https://doi.org/10.1016/j.fertnstert.2014.05.010
MAGNUSSEN, Line V. et al. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy. Diabetes, Obesity and Metabolism, v. 18, n. 10, p. 980-989, 2016. DOI: https://doi.org/10.1111/dom.12701
MAGNUSSEN, Line Velling et al. Testosterone therapy preserves muscle strength and power in aging men with type 2 diabetes—a randomized controlled trial. Andrology, v. 5, n. 5, p. 946-953, 2017. DOI: https://doi.org/10.1111/andr.12396
MAGNUSSEN, Line Velling. Testosterone therapy of men with type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled study. Danish Medical Journal, v. 64, n. 7, p. B5396, 2017.
ROBLEDO, Kristy P. et al. Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial. European Journal of Endocrinology, v. 189, n. 1, p. 50-57, 2023. DOI: https://doi.org/10.1093/ejendo/lvad074
ROBLEDO, Kristy P. et al. Predicting type 2 diabetes and testosterone effects in high-risk Australian men: development and external validation of a 2-year risk model. European Journal of Endocrinology, v. 192, n. 1, p. 15-24, 2025. DOI: https://doi.org/10.1093/ejendo/lvae166
ZHANG, Jianzhong et al. Association between testosterone with type 2 diabetes in adult males, a meta-analysis and trial sequential analysis. The Aging Male, 2020. DOI: https://doi.org/10.1080/13685538.2018.1557139
ZHANG, K.-S. et al. Effects of testosterone supplementation therapy on lipid metabolism in hypogonadal men with T2DM: a meta‐analysis of randomized controlled trials. Andrology, v. 6, n. 1, p. 37-46, 2018. DOI: https://doi.org/10.1111/andr.12425
Descargas
Publicado
Licencia
Derechos de autor 2025 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.
